Frisch Financial Group, Inc. Gsk PLC Transaction History

Frisch Financial Group, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	BUY	$38.79 - $43.16 $502,020 - $558,576	12,942 New	12,942 $0
Q2 2021 Aug 12, 2021	SELL	$36.52 - $41.46 $210,793 - $239,307	-5,772 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$34.27 - $40.01 $7,710 - $9,002	225 Added 4.06%	5,772 $206,000
Q4 2020 Jan 26, 2021	SELL	$34.07 - $39.94 $8,279 - $9,705	-243 Reduced 4.2%	5,547 $204,000
Q3 2020 Nov 10, 2020	BUY	$38.11 - $42.99 $2,400 - $2,708	63 Added 1.1%	5,790 $218,000
Q2 2020 Aug 06, 2020	BUY	$37.87 - $43.58 $2,878 - $3,312	76 Added 1.34%	5,727 $233,000
Q1 2020 May 08, 2020	SELL	$32.47 - $48.83 $6,169 - $9,277	-190 Reduced 3.25%	5,651 $214,000
Q4 2019 Jan 28, 2020	BUY	$42.0 - $48.25 $2,226 - $2,557	53 Added 0.92%	5,841 $274,000
Q3 2019 Nov 05, 2019	BUY	$40.46 - $43.52 $234,182 - $251,893	5,788 New	5,788 $247,000
Q2 2019 Aug 08, 2019	SELL	$39.4 - $42.7 $191,917 - $207,991	-4,871 Closed	0 $0
Q1 2019 May 06, 2019	SELL	$38.57 - $42.69 $14,039 - $15,539	-364 Reduced 6.95%	4,871 $204,000
Q4 2018 Feb 14, 2019	BUY	$37.8 - $42.69 $197,882 - $223,482	5,235 New	5,235 $200,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Frisch Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Frisch Financial Group, Inc. with notifications on news.